<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03371537</url>
  </required_header>
  <id_info>
    <org_study_id>RIPH3-RNI17/DEBIFOIE</org_study_id>
    <secondary_id>2017-A01754-49</secondary_id>
    <secondary_id>2017-61</secondary_id>
    <nct_id>NCT03371537</nct_id>
  </id_info>
  <brief_title>Study of Hemodynamic Conditions Measured During Hepatectomy</brief_title>
  <acronym>DEBIFOIE</acronym>
  <official_title>Study of Hemodynamic Conditions Measured During Hepatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatocellular insufficiency is a dreaded complication after hepatectomy, since, if it is
      persistent, it leads to the death of the patient in the absence of liver transplantation.

      The preoperative evaluation aims in particular to estimate the risk of postoperative
      hepatocellular insufficiency so as to minimize or contraindicate high-risk patients.

      It has been shown that the flow of the portal vein is correlated with liver function,
      especially in the living donor and after portal embolization. More recently, the study of
      flow rates in the portal vein and the hepatic artery after transplantation has shown a
      correlation with the recovery of graft function.

      The hypothesis is that portal and arterial flow after hepatectomy can predict postoperative
      hepatocellular function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Measurements of flow rates in the portal vein and the hepatic artery by different transit
      times are available thanks to the Medistim VeriQTM system that the investigators already use
      routinely in the context of liver transplantation when performing hepatectomies.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Liver vessel debit</measure>
    <time_frame>Baseline</time_frame>
    <description>Mesure of liver debit during hepatectomy</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Liver Dysfunction</condition>
  <condition>Circulatory; Change</condition>
  <arm_group>
    <arm_group_label>Hepatectomy</arm_group_label>
    <description>Patient undergoing laparotomy for liver resection. The aim is to measure the flow rates in the portal vein and the hepatic artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liver debit measure</intervention_name>
    <description>Mesure of liver debit during hepatectomy</description>
    <arm_group_label>Hepatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient undergoing laparotomy for liver resection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient 18 years or more

          -  Patient undergoing laparotomy for liver resection

        Exclusion Criteria:

          -  Patient under tutorship or curatorship

          -  Pregnant or lactating woman

          -  Difficulties in understanding French

          -  Patient operated by laparoscopy

          -  Patient having objected to the processing of his data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ephrem SALAME, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Tours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Louise BARBIER, MD</last_name>
    <phone>02.47.47.59. 37</phone>
    <phone_ext>+33</phone_ext>
    <email>louise.barbier@chu-tours.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabien FREDON, MD-PhD</last_name>
    <phone>02.47.47.59. 37</phone>
    <phone_ext>+33</phone_ext>
    <email>F.FREDON@chu-tours.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Chirurgie Digestive, Oncologique, Endocrinienne et Transplantation HÃ©patique, CHRU de TOURS</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louise BARBIER, MD</last_name>
      <phone>02.47.47.59. 37</phone>
      <phone_ext>+33</phone_ext>
      <email>louise.barbier@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Ephrem SALAME, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2017</study_first_submitted>
  <study_first_submitted_qc>December 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

